Clincosm LogoSign in Get a demo

recurrent gliosarcoma

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen

Not yet recruiting
  • High Grade Astrocytic Tumor
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 18, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)

Recruiting
  • Recurrent Glioblastoma
  • +5 more
  • Mycophenolate Mofetil
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 7, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived

Not yet recruiting
  • Recurrent Gliosarcoma
  • +2 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • Resection
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)

Recruiting
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 23, 2022

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,

Withdrawn
  • Recurrent Glioblastoma
  • +3 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 10, 2021

Recurrent Glioblastoma Multiforme, Recurrent Gliosarcoma Trial in Tucson (temozolomide and bevacizumab)

Completed
  • Recurrent Glioblastoma Multiforme
  • Recurrent Gliosarcoma
  • temozolomide and bevacizumab
  • Tucson, Arizona
    Center for Neurosciences
Mar 28, 2017